Skip to main content
Corona Remedies Limited logo

Corona Remedies Limited — Investor Relations & Filings

Ticker · CORONA ISIN · INE02ZQ01018 LEI · 894500F0QWX23PSWWE23 BSE.NS Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS CORONA

About Corona Remedies Limited

https://www.coronaremedies.com

Corona Remedies Limited is a pharmaceutical organization focused on the development, manufacturing, and marketing of a diverse range of therapeutic solutions. The company maintains a significant presence in key medical segments, including gynecology, cardio-diabetic care, orthopedics, nutraceuticals, and pediatrics. It operates advanced manufacturing facilities that adhere to international quality standards, supported by robust research and development capabilities aimed at creating innovative formulations. Corona Remedies emphasizes a patient-centric approach, delivering high-quality medications through an extensive distribution network. Its portfolio includes both legacy brands and novel therapeutic entries, catering to various chronic and acute conditions. The organization is recognized for its commitment to clinical excellence and its strategic focus on expanding its footprint across multiple specialized healthcare verticals.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-05-26 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a compliance declaration filed under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (Regulation 31(4)) stating that the promoter and persons acting in concert have not encumbered shares during the financial year. It is a routine regulatory announcement of share encumbrance status under Indian securities law rather than an actual financial report, voting result, insider trade, share issuance, or other specific filing. It therefore falls under the general “Regulatory Filings” category (RNS) as a miscellaneous compliance filing.
2026-05-25 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 92% confidence The document is a regulatory disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (Regulation 31(4)) declaring that no encumbrance has been created on the promoter’s shares. It is not a financial report, AGM material, earnings release, or any major share acquisition or capital change—it is a statutory filing required by stock exchanges. This fits best into the general "Regulatory Filings" category as a miscellaneous compliance announcement.
2026-05-22 English
Updates
Notice of Dividend Amount Classification · 89% confidence The document is a formal communication from the company to stock exchanges and shareholders regarding the Board’s recommendation of a final dividend, record date, payment instructions, and detailed tax withholding (TDS) procedures on the dividend. It is not a financial report or management change notice, but an announcement of dividend amount, eligibility, and related processes. Hence it falls under the dividend notice category.
2026-05-21 English
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Notice of Dividend Amount Classification · 85% confidence The document is a formal communication to stock exchanges and shareholders regarding the Board’s recommendation of a final dividend (₹10 per share) for FY 2025-26, the record date, and instructions on dividend payment and tax withholding (TDS) procedures. It principally announces dividend amount, record date, and payment details, fitting the “Notice of Dividend Amount” category rather than a full annual/interim report or regulatory filing. Hence, it is classified as DIV.
2026-05-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a formal letter addressed to stock exchanges informing about the company's participation in upcoming analyst/investor conferences. It references compliance with SEBI regulations and provides details of the events, including dates, hosts, and modes of attendance. The content is an announcement of participation in investor conferences, not the transcript or detailed presentation itself. There is no financial data, report, or detailed analysis included. This fits the category of an Investor Presentation announcement or update. However, since it is only an intimation of participation and not the presentation material itself, it aligns best with the Investor Presentation (IP) category as it relates to investor-focused events and presentations.
2026-05-19 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.